Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

Published:2015-03 Issue:3 Volume:3 Page:190-200
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Ndiaye Birahim Pierre,Thienemann Friedrich,Ota Martin,Landry Bernard S,Camara Makhtar,Dièye Siry,Dieye Tandakha Ndiaye,Esmail Hanif,Goliath Rene,Huygen Kris,January Vanessa,Ndiaye Ibrahima,Oni Tolu,Raine Michael,Romano Marta,Satti Iman,Sutton Sharon,Thiam Aminata,Wilkinson Katalin A,Mboup Souleymane,Wilkinson Robert J,McShane Helen

Funder

European & Developing Countries Clinical Trials Partnership

Aeras

Bill & Melinda Gates Foundation

Wellcome Trust

Oxford-Emergent Tuberculosis Consortium

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. Global tuberculosis report,2014

2. HIV-1 and the immune response to TB;Walker;Future Virol,2013

3. Drug-resistant tuberculosis: latest advances;Falzon;Lancet Respir Med,2013

4. Tuberculosis vaccines: a strategic blueprint for the next decade;Brennan;Tuberculosis,2012

5. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis;Rodrigues;Int J Epidemiol,1993

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A modular self-assembling and self-adjuvanting multiepitope peptide nanoparticle vaccine platform to improve the efficacy and immunogenicity of BCG;2024-08-05

2. Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naïve mice;Mucosal Immunology;2024-07

3. Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by 18FDG-PET/CT at time of diagnosis, 6- and 12-months follow-up: classifying clinical stages of spinal tuberculosis and monitoring treatment response (Spinal TB X cohort study);Journal of Orthopaedic Surgery and Research;2024-06-25

4. Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses;npj Vaccines;2024-06-06

5. Tuberculosis Vaccines and T Cell Immune Memory;Vaccines;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3